Boston Scientific (NYSE:BSX) Price Target Raised to $64.00 at Canaccord Genuity Group
Boston Scientific (NYSE:BSX – Free Report) had its price target raised by Canaccord Genuity Group from $60.00 to $64.00 in a report released on Monday, Benzinga reports. Canaccord Genuity Group currently has a buy rating on the medical equipment provider’s stock. A number of other equities research analysts have also weighed in on BSX. Mizuho […]
More Stories
Keyvan Mohajer Sells 121,194 Shares of SoundHound AI, Inc. (NASDAQ:SOUN) Stock
SoundHound AI, Inc. (NASDAQ:SOUN – Get Free Report) CEO Keyvan Mohajer sold 121,194 shares of SoundHound AI stock in a...
Accolade, Inc. (NASDAQ:ACCD) Receives Consensus Rating of “Moderate Buy” from Analysts
Accolade, Inc. (NASDAQ:ACCD – Get Free Report) has been assigned a consensus rating of “Moderate Buy” from the fourteen analysts...
Analysts Set Amicus Therapeutics, Inc. (NASDAQ:FOLD) Target Price at $16.88
Shares of Amicus Therapeutics, Inc. (NASDAQ:FOLD – Get Free Report) have received a consensus recommendation of “Moderate Buy” from the...
Amanda Long Sells 200,000 Shares of BigBear.ai Holdings, Inc. (NYSE:BBAI) Stock
BigBear.ai Holdings, Inc. (NYSE:BBAI – Get Free Report) CEO Amanda Long sold 200,000 shares of BigBear.ai stock in a transaction...
Insider Buying: CVR Partners, LP (NYSE:UAN) Major Shareholder Buys 6,236 Shares of Stock
CVR Partners, LP (NYSE:UAN – Get Free Report) major shareholder Carl C. Icahn purchased 6,236 shares of the business’s stock...
SoundHound AI, Inc. (NASDAQ:SOUN) CFO Sells $1,172,548.30 in Stock
SoundHound AI, Inc. (NASDAQ:SOUN – Get Free Report) CFO Nitesh Sharan sold 57,761 shares of the stock in a transaction...